AFME.PA stock jumped intraday after a surge in trading volume, sending the price to EUR 2.76, a +38.00% move from yesterday. The stock traded between EUR 2.15 and EUR 2.88 today on EURONEXT in Europe. Volume reached 298,673 shares versus an average of 17,633, marking AFME.PA as a high volume mover during this intraday session. Traders should note the spike came with technical momentum but mixed fundamentals.
Intraday price and volume for AFME.PA stock
AFME.PA stock closed the intraday move at EUR 2.76 after opening at EUR 2.16. The session range was EUR 2.15 to EUR 2.88, with volume at 298,673 shares compared to an average volume of 17,633. The relative volume is approximately 2.40, confirming strong intraday participation and interest from buyers and sellers.
Fundamentals and valuation snapshot for AFME.PA stock
Affluent Medical SA shows thin revenues and negative earnings with EPS of -0.36 and a trailing PE of -5.47. Market capitalization stands near EUR 77,416,692.00 with price to sales at 16.49 and price to book at 3.67. The balance sheet shows cash per share EUR 0.14 and book value per share EUR 0.54, reflecting early-stage commercialisation and a stretched valuation.
Technical indicators and trading signals for AFME.PA stock
Momentum indicators are positive intraday. RSI sits at 64.09, MACD histogram is 0.03, and ADX reads 34.62, indicating a strong trend. The 50-day average is EUR 1.69 and the 200-day average is EUR 1.50, both well below today’s price. The volume surge pushed OBV higher and MFI to 79.38, suggesting buyer strength but possible short-term overbought conditions.
Meyka stock grade and analyst context for AFME.PA stock
Meyka AI rates AFME.PA with a score out of 100: 57.38 (Grade C+) with a suggestion to HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating highlights constructive momentum but flags weak profitability and high valuation. These grades are informational and not financial advice.
Catalysts, sector context and risks for AFME.PA stock
Affluent Medical SA operates in Healthcare, Medical – Devices, where sector ROE averages near 9.82 and sector performance has been muted. Near-term catalysts include device approvals, trial readouts, and small commercial milestones. Key risks are persistent losses, long receivables cycles, and debt-to-equity at 1.11, which raise liquidity and execution risks for AFME.PA stock.
Price targets and forecast for AFME.PA stock
Meyka AI’s forecast model projects a yearly price of EUR 1.56 versus the current EUR 2.76, implying a downside of -43.48%. Short-term model outputs show a quarterly figure EUR 2.27 and monthly EUR 1.92. We set pragmatic scenarios: conservative target EUR 1.50 (-45.65%), base target EUR 2.50 (-9.42%), and bull target EUR 4.00 (+44.93%). Forecasts are model-based and not guarantees.
Final Thoughts
AFME.PA stock is the clear intraday high volume mover on EURONEXT today, trading at EUR 2.76 on volume of 298,673 shares. Technical momentum is bullish for now, with RSI 64.09 and ADX 34.62, but fundamentals remain weak with EPS -0.36 and high price-to-sales of 16.49. Meyka AI’s forecast model projects a yearly price of EUR 1.56, implying a -43.48% decline from the current level. That forecast reflects mixed signals: strong trading interest but limited earnings power. Traders who prefer momentum strategies may watch intraday support near EUR 2.15 and resistance near EUR 2.88. Longer-term investors should weigh regulatory milestones and cash runway against valuation risks. All forecasts are model-based projections and not guarantees. For the latest market updates and AFME.PA stock news, see the trading feed and recent coverage on major financial sites source and comparative sector updates source. Meyka AI provides this as an AI-powered market analysis platform, not investment advice.
FAQs
Why did AFME.PA stock spike in volume today?
AFME.PA stock spiked due to a large intraday volume surge of 298,673 shares. High relative volume and positive technical signals drove price momentum. Newsflow around device trials or trading interest often causes such spikes.
What is Meyka AI’s short-term view on AFME.PA stock?
Meyka AI’s model shows a short-term quarterly projection of EUR 2.27. That implies downside versus the intraday price, highlighting momentum risk. Models are projections and not guarantees.
How do fundamentals affect AFME.PA stock outlook?
Fundamentals weigh on AFME.PA stock because EPS is -0.36 and price-to-sales is 16.49. High valuation and negative earnings raise longer-term risk despite intraday momentum.
What price targets should traders use for AFME.PA stock?
Use scenario targets: conservative EUR 1.50, base EUR 2.50, bull EUR 4.00. Adjust targets to risk tolerance and monitor liquidity, regulatory news, and cash runway.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)